US FTC expands probe into pharmacy benefit managers
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
CVS Health (CVS) already bakes in more than the worst-case scenario, TD Cowen 'would add here'
May 19, 2023 2:04 PM EDTTD Cowen analyst Charles Rhyee reiterated an Outperform rating and $111 price target on CVS Health (NYSE: CVS) in a note Friday, telling investors that the current trough valuation "overly discounts" near-term risks.
"We would add here," said Rhyee. "Concerns over a number of... More
